Method of using a composition for enhancing newborn infant cognitive, brain and/or CNS development
AssigneeAbbott Laboratories
InventorsChron-si Lai, Matthew Kuchan
Life of this patent
Estimating the term…
Abstract
Disclosed are methods of using nutritional compositions generally, and infant formulas specifically, to improve cognitive, brain and/or central nervous system development in an individual. The nutritional compositions include a combination of RRR-alpha tocopherol acetate, non-RRR-alpha-tocopherol stereoisomers, fat, and protein. The amount of non-RRR alpha tocopherol stereoisomers in the nutritional compositions is limited.
Claims8
A method for enhancing central nervous system development in an infant, toddler, or child, the method comprising administering to the infant, toddler, or child a nutritional composition comprising:
- i) from about 20 g/L to about 50 g/L of fat;
- ii) from about 10 g/L to about 15 g/L of protein;
- iii) from about 5 mg/L to about 100 mg/L of RRR-alpha tocopherol acetate;
- iv) less than about 8 mg/L of non-RRR-alpha-tocopherol isomers;
- v) at least about 130 mg/L of ascorbic acid;
- vi) from about 60 mg/L to about 180 mg/L of DHA, where the concentration of DHA is based on the nutritional composition;
- and
- vii) from about 120 mg/L to about 360 mg/L of ARA, where the concentration of ARA is based on the nutritional composition;
- wherein the DHA to RRR-alpha tocopherol acetate ratio is from about 7.5:1 to about 20:1 and the ARA to RRR-alpha tocopherol acetate ratio is from about 15:1 to about 40:1, and wherein the ratio of RRR-alpha-tocopherol acetate to non-RRR-alpha-tocopherol isomers is from 1:5 to 99:1.
Dependencies are inferred from the claim text.